A detailed history of Swiss National Bank transactions in Immunome Inc. stock. As of the latest transaction made, Swiss National Bank holds 76,400 shares of IMNM stock, worth $725,800. This represents 0.0% of its overall portfolio holdings.

Number of Shares
76,400
Previous 76,400 -0.0%
Holding current value
$725,800
Previous $924,000 20.78%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

BUY
$11.54 - $22.11 $57,699 - $110,550
5,000 Added 7.0%
76,400 $924,000
Q1 2024

May 07, 2024

BUY
$11.01 - $27.34 $786,114 - $1.95 Million
71,400 New
71,400 $1.76 Million

Others Institutions Holding IMNM

About Immunome Inc.


  • Ticker IMNM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 12,127,400
  • Market Cap $115M
  • Description
  • Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01, which targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system. It also develops IMM-BCP-01, an antibody cocktail product ca...
More about IMNM
Track This Portfolio

Track Swiss National Bank Portfolio

Follow Swiss National Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.